Skip to main content

Table 1 Baseline characteristics of individuals who died from CVD and those who did not die

From: Evaluating the potential of waist-to-BMI ratio, a body shape index, and other anthropometric parameters in predicting cardiovascular disease mortality: evidence from NHANES III

Variables

All (N = 6,746)

CVD mortality

p-value

Yes (n = 1,424)

No (n = 5,322)

Follow-up time, years

20.3 ± 8.8

14.2 ± 7.8

21.9 ± 8.3

< 0.001

FRS

9.9 ± 8.8

13.7 ± 9.2

8.9 ± 8.4

< 0.001

BMI, kg/m2

27.9 ± 5.6

28.2 ± 5.6

27.8 ± 5.6

0.035

Waist circumference, cm

97.1 ± 13.6

99.4 ± 13.8

96.5 ± 13.5

< 0.001

Waist-to-BMI ratio, cm · m2/kg

3.53 ± 0.35

3.58 ± 0.35

3.52 ± 0.35

< 0.001

BRI

5.2 ± 1.9

5.5 ± 1.9

5.1 ± 1.9

< 0.001

ABSI, m11/6/kg2/3

0.0822 ± 0.050

0.0837 ± 0.0049

0.0819 ± 0.0050

< 0.001

Age, years

57.6 ± 11.5

64.7 ± 9.9

55.7 ± 11.1

< 0.001

 40–49

2091 (31.0)

156 (11.0)

1935 (36.4)

< 0.001

 50–59

1512 (22.4)

205 (14.4)

1307 (24.6)

 

 60–69

1818 (26.9)

514 (36.1)

1304 (24.5)

 

 70–79

1325 (19.6)

549 (38.6)

776 (14.6)

 

Sex

   

0.002

 Male

3280 (48.6)

744 (52.2)

2536 (47.7)

 

 Female

3466 (51.4)

680 (47.8)

2786 (52.3)

 

Race/ethnicity

   

< 0.001

 Non-Hispanic white

3257 (48.3)

742 (52.1)

2515 (47.3)

 

 Non-Hispanic black

1658 (24.6)

361 (25.4)

1297 (24.4)

 

 Mexican-American

1566 (23.2)

288 (20.2)

1278 (24.0)

 

 Other

265 (3.9)

33 (2.3)

232 (4.4)

 

Education level

   

< 0.001

 < 12 years

2908 (43.1)

758 (53.2)

2150 (40.4)

 

 ≥ 12 years

3838 (56.9)

666 (46.8)

3172 (59.6)

 

Poverty index

   

0.012

 Poor (< 1)

1266 (18.8)

300 (21.1)

966 (18.2)

 

 Not poor (≥ 1)

5480 (81.2)

1124 (78.9)

4356 (81.8)

 

Smoking status

   

0.002

 Non-smoker

2883 (42.7)

568 (39.9)

2315 (43.5)

 

 Former smoker

2219 (32.9)

523 (36.7)

1696 (31.9)

 

 Current smoker

1644 (24.4)

333 (23.4)

1311 (24.6)

 

DM

1215 (18.0)

384 (27.0)

831 (15.6)

< 0.001

CVD history

723 (10.7)

336 (23.6)

387 (7.3)

< 0.001

COPD

605 (9.0)

160 (11.2)

445 (8.4)

< 0.001

HTN

4245 (62.9)

1105 (77.6)

3140 (59.0)

< 0.001

eGFR, mL/min/1.73 m²

   

< 0.001

 < 60

2605 (38.6)

712 (50.0)

1893 (35.6)

 

 ≥ 60

4141 (61.4)

712 (50.0)

3429 (64.4)

 

SBP, mm Hg

130.1 ± 20.8

138.5 ± 22.2

127.8 ± 19.9

< 0.001

DBP, mm Hg

74.9 ± 11.4

74.9 ± 12.2

74.9 ± 11.2

0.926

Total cholesterol, mg/dL

217.9 ± 43.4

223.7 ± 43.9

216.3 ± 43.2

< 0.001

LDL-C, mg/dL

135.1 ± 39.7

140.3 ± 40.8

133.8 ± 39.3

< 0.001

HDL-C, mg/dL

50.7 ± 16.4

50.0 ± 16.6

50.9 ± 16.3

0.046

HbA1c, %

5.8 ± 1.3

6.1 ± 1.6

5.7 ± 1.2

< 0.001

Fasting plasma glucose, mg/dL

108.3 ± 44.0

117.1 ± 55.1

106.0 ± 40.2

< 0.001

  1. ABSI, a body shape index; BMI, body mass index; BRI, body roundness index; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FRS, Framingham risk score; HbA1c, glycated hemoglobin; HDL-C, high-density lipoprotein cholesterol; HTN, hypertension; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure
  2. Continuous variables are presented as mean ± standard deviation; categorical variables are presented as count (%)
  3. P-value < 0.05 are shown in bold
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us